SARS-Cov-2 Recombinant Antigen – R&D Samples Available

Published: 02.06.2020

undefinedWe are finalizing the development of SARS-Cov-2 Spike RBD recombinant antigen. The antigen is produced in mammalian cells and could be used in serology assays. The product is lyophilized, which makes its shipment and storage convenient.

See all our COVID-19 Products

Terms: The sample opportunity is only available to end users. Distributors and re-sellers are not included in this promotion.
The usual shipping and handling costs will still apply. The sample opportunity is a one-time evaluation possibility and you can get more details by contacting HyTest customer service.

Sign up to our newsletter

And be informed about new products and scientific findings

Thank you for your subscription!